<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05060770</url>
  </required_header>
  <id_info>
    <org_study_id>2021PI125</org_study_id>
    <nct_id>NCT05060770</nct_id>
  </id_info>
  <brief_title>Transcriptomic Study of IBD-associated Colorectal Cancer</brief_title>
  <official_title>Transcriptiomic Analysis of Inflammatory Bowel Disease-associated Colorectal Cancer. A French Retrospective Study of 26 Cases Identified at the Nancy University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic inflammatory bowel disease (IBD) is associated with an increased risk of colorectal&#xD;
      cancer (CRC) in historical cohorts. The pathways of oncogenesis of these CRCs, which are very&#xD;
      different clinically from de novo CRCs, are currently unknown. The aim of our work is to&#xD;
      identify specific molecular signatures of CRC occurring in the setting of IBD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>IBD associated CRC oncogenesis</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of gene expression variation in CRC tumor tissue samples in the following groups patients with CRC and IBD</description>
  </primary_outcome>
  <enrollment type="Actual">26</enrollment>
  <condition>Colorectal Cancer, Genetics of</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>transcriptomic analysis</intervention_name>
    <description>transcriptomic analysis on preserved tumor tissue</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        &gt;/= 18 years old patient operated on at the Nancy university hospital for IBD associated&#xD;
        CRC&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Person 18 years of age or older&#xD;
&#xD;
          -  Person with colorectal cancer in the context of IBD&#xD;
&#xD;
          -  Person who has received complete information on the organization of the research and&#xD;
             who has signed an informed consent&#xD;
&#xD;
          -  Person affiliated to a social security plan or beneficiary of such a plan.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Person referred to in articles L. 1121-5, L. 1121-7 and L1121-8 of the public health&#xD;
             code:&#xD;
&#xD;
          -  Pregnant woman, parturient or nursing mother&#xD;
&#xD;
          -  Minor (not emancipated)&#xD;
&#xD;
          -  Adult person subject to a legal protection measure (guardianship, curatorship,&#xD;
             safeguard of justice)&#xD;
&#xD;
          -  Person of legal age who is unable to express his or her consent&#xD;
&#xD;
          -  Person deprived of liberty by a judicial or administrative decision, persons subject&#xD;
             to psychiatric care under articles L. 3212-1 and L. 3213-1.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
  </eligibility>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 19, 2021</study_first_submitted>
  <study_first_submitted_qc>September 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>MULLER Marie</investigator_full_name>
    <investigator_title>Doctor (MD, PhD Student), Principal investigator</investigator_title>
  </responsible_party>
  <keyword>inflammatory bowel disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

